Discontinued — last reported Q3 '25

Non-Current Assets

Equity Method Investments

Bunge Equity Method Investments increased by 4.4% to $142.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.9%, from $175.00M to $142.00M. Over 3 years (FY 2022 to FY 2025), Equity Method Investments shows a downward trend with a -48.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2025

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

11 periods
 Q4 '22Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.01B$1.28B$159.00M$168.00M$174.00M$779.00M$175.00M$172.00M$181.00M$136.00M$142.00M
QoQ Change+26.5%-87.6%+5.7%+3.6%+347.7%-77.5%-1.7%+5.2%-24.9%+4.4%
YoY Change+26.5%-39.1%+10.1%+2.4%+4.0%-82.5%-18.9%
Range$136.00M$1.28B
CAGR-54.4%
Avg YoY Growth-13.9%
Median YoY Growth+2.4%

Business Segments

View all
SegmentQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q4 '25
Grain Merchandising and Milling$0.50
Soybean Processing and Refining$0.50
Agribusiness$0.57$0.57
Sugar and Bioenergy$0.50$0.50$0.50$0.50$0.50
Total$1.28B$159.00M$168.00M$174.00M$779.00M$136.00M

Agribusiness, Sugar and Bioenergy were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Equity Method Investments at Other Companies

Frequently Asked Questions

What is Bunge's equity method investments?
Bunge (BG) reported equity method investments of $142.00M in Q1 2026.
How has Bunge's equity method investments changed year-over-year?
Bunge's equity method investments decreased by 18.9% year-over-year, from $175.00M to $142.00M.
What is the long-term trend for Bunge's equity method investments?
Over 3 years (2022 to 2025), Bunge's equity method investments has grown at a -48.8% compound annual growth rate (CAGR), from $1.01B to $136.00M.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.